URGN
URGN
IL0011407140
UroGen Pharma Ltd.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 109.788.000 90.398.000
21.4%
Cost of Revenue 12.447.000 8.881.000
40.2%
Gross Profit 97.341.000 81.517.000
19.4%
222.204.000 178.299.000
24.6%
Operating Income -124.863.000 -96.782.000
29.0%
Pretax Income -153.416.000 -124.042.000
23.7%
Net Income Common Stockholders -153.494.000 -126.874.000
21.0%
-- --
--
-- --
--
ende